Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
15.04
+0.32 (2.17%)
Nov 22, 2024, 4:00 PM EST - Market closed
Assembly Biosciences Employees
Assembly Biosciences had 65 employees as of December 31, 2023. The number of employees decreased by 3 or -4.41% compared to the previous year.
Employees
65
Change (1Y)
-3
Growth (1Y)
-4.41%
Revenue / Employee
$435,785
Profits / Employee
-$627,754
Market Cap
95.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
EDAP TMS | 307 |
Adagene | 174 |
Adlai Nortye | 127 |
Lineage Cell Therapeutics | 75 |
Leap Therapeutics | 54 |
Regulus Therapeutics | 30 |
Annovis Bio | 16 |
ASMB News
- 4 months ago - Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop - GlobeNewsWire
- 5 months ago - Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 - GlobeNewsWire
- 6 months ago - Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024 - GlobeNewsWire
- 7 months ago - Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 8 months ago - Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights - GlobeNewsWire
- 10 months ago - Assembly Biosciences Announces Effective Date of Reverse Stock Split - GlobeNewsWire
- 11 months ago - Assembly Biosciences Provides Anticipated Development Milestones for 2024 - GlobeNewsWire
- 1 year ago - Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire